The research models and services provider has acquired a company that specializes in tissue collections, and hematology, and immunology cell isolations to help meet its ‘ever-increasing’ client needs.
Key Biologics and Cascade Regional Blood Services’ multi-year agreement will provide researchers with the critical raw material needed for developing cell- and gene-based therapies.
Marking its sixth acquisition since 2017, BioIVT this week purchased Biological Specialty Corporation (BSC), which expands its ability to offer fresh blood products.